Coronavirus: Regeneron’s antiviral cocktail reduces viral load and need for medical care, trial shows

//Coronavirus: Regeneron’s antiviral cocktail reduces viral load and need for medical care, trial shows

Coronavirus: Regeneron’s antiviral cocktail reduces viral load and need for medical care, trial shows

Regeneron Pharmaceuticals said data from a late-stage clinical trial suggest that its antibody cocktail therapy for Covid-19 significantly reduces virus levels and the need for further medical care.Patients getting the therapy were 57 per cent less likely to need medical care within a month of treatment, with 2.8 per cent of those given the antibody and 6.5 per cent of those on placebo seeing a health care worker within 29 days.The Tarrytown, New York-based company has shared the results with…

Article by [author-name] (c) South China Morning Post - Read full story here.

By | 2020-10-28T22:53:57+00:00 October 28th, 2020|World|Comments Off on Coronavirus: Regeneron’s antiviral cocktail reduces viral load and need for medical care, trial shows